Keyphrases
Statin Therapy
100%
Placebo
100%
Angiotensin II (Ang II)
100%
Vasodilator
100%
Hypercholesterolemia
100%
Vascular Sensitivity
100%
Statins
60%
Vasoconstriction
60%
Angiotensin II Type 1 Receptor (AT1R)
40%
Angiotensin I
40%
Noradrenaline
40%
Cardiovascular Risk
20%
Randomized Placebo-controlled Trial
20%
Renin-angiotensin System
20%
Venous Occlusion Plethysmography
20%
Intra-arterial Infusion
20%
Brachial Artery
20%
AT2 Receptor
20%
Cholesterol-lowering Therapy
20%
Cholesterol-lowering Treatment
20%
Angiotensin-converting Enzyme II
20%
Total Cholesterol Level
20%
Medicine and Dentistry
Angiotensin II
100%
Statin
100%
Placebo
75%
Hypercholesterolemia
62%
Vasoconstrictor
62%
Vasoconstriction
37%
Receptor
25%
Noradrenalin
25%
Angiotensin I
25%
Cardiovascular Risk
12%
Analysis of Variance
12%
Angiotensin Receptor
12%
Renin Angiotensin Aldosterone System
12%
Brachial Artery
12%
Vein Occlusion Plethysmography
12%
Downregulation
12%
Intraarterial Drug Administration
12%
Angiotensin Converting Enzyme 2
12%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
100%
Angiotensin II
100%
Placebo
85%
Hypercholesterolemia
71%
Receptor
28%
Angiotensin I
28%
Noradrenalin
28%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
14%
Vein Occlusion
14%
Cardiovascular Risk
14%
Renin
14%
Angiotensin
14%
Angiotensin Receptor
14%
Angiotensin Converting Enzyme 2
14%